Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2017, Article ID 3026370, 13 pages
https://doi.org/10.1155/2017/3026370
Review Article

Phytochemical and Pharmacological Review of Cryptolepis sanguinolenta (Lindl.) Schlechter

Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Correspondence should be addressed to Newman Osafo; hg.ude.tsunk@mrahp.ofason

Received 5 June 2017; Revised 14 August 2017; Accepted 12 September 2017; Published 15 October 2017

Academic Editor: Antonio Ferrer-Montiel

Copyright © 2017 Newman Osafo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. Boye and O. Ampofo, Proceedings of the First International Symposium on Cryptolepine, University of Science and Technology, Kumasi, Ghana, 1983.
  2. F. R. Irvine, Woody Plants of Ghana, Oxford University Press, London, UK, 1961.
  3. E. S. Ayensu, Medicinal Plants of West Africa, Reference publications Inc., Algonac, Mich, USA, 1978.
  4. O. B. Dokosi, Herbs of Ghana, African Universities Press, Accra, Ghana, 1988.
  5. E. Gellért, Raymond‐Hamet, and E. Schlittler, “Die Konstitution des Alkaloids Cryptolepin,” Helvetica Chimica Acta, vol. 34, no. 2, pp. 642–651, 1951. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Dwuma‐Badu, J. S. K. Ayim, N. I. Y. Fiagbe, J. E. Knapp, P. L. Schiff, and D. J. Slatkin, “Constituents of West African medicinal plants XX: quindoline from Cryptolepis sanguinolenta,” Journal of Pharmaceutical Sciences, vol. 67, no. 3, pp. 433-434, 1978. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ajayi, R. Akhigbe, O. Adewumi, and S. Olaleye, “Haematological evaluation of Cryptolepis sanguinolenta stem ethanolic extract in rats,” International Journal of Medicine and Biomedical Research, vol. 1, no. 1, pp. 56–61, 2012. View at Publisher · View at Google Scholar
  8. C. W. Wright, “Plant derived antimalarial agents: new leads and challenges,” Phytochemistry Reviews, vol. 4, no. 1, pp. 55–61, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Wiart, Lead Compounds from Medicinal Plants for The Treatment of Neurodegenerative Disesases, Academic Press, Cambridge, Mass, USA, 2013.
  10. S. O. A. Bamgbose and B. K. Noamesi, “Studies on cryptolepine II: inhibition of carrageenan induced oedema by cryptolepine,” Planta Medica, vol. 41, no. 4, pp. 392–396, 1981. View at Publisher · View at Google Scholar · View at Scopus
  11. O. A. Olajide, A. M. Ajayi, and C. W. Wright, “Anti-inflammatory properties of cryptolepine,” Phytotherapy Research, vol. 23, no. 10, pp. 1421–1425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Ajayi and R. Akhigbe, “Antifertility activity of Cryptolepis sanguinolenta leaf ethanolic extract in male rats,” Journal of Human Reproductive Sciences, vol. 5, no. 1, pp. 43–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. P. C. M. Jansen and G. H. Schmelzer, “Cryptolepis sanguinolenta (Lindl.) Schltr,” in Plant Resources of Tropical Africa (Prota), G. H. Schmelzer and A. Gurib-Fakim, Eds., 2010, http://uses.plantnet-project.org/en/Cryptolepis_sanguinolenta_(PROTA). View at Google Scholar
  14. J. E. Saxton, The Alkaloids, Chemistry and Physiology, R. H. F. Manske and H. L. Holmes, Eds., vol. 8, Academic Press, New York, NY, USA, 1965.
  15. K. Boakye-Yiadom, “Antimicrobial properties of some west african medicinal plants II. Antimicrobial activity of aqueous extracts of cryptolepis sanguinolenta (lindl.) schlechter,” Pharmaceutical Biology, vol. 17, no. 2, pp. 78–80, 1979. View at Publisher · View at Google Scholar · View at Scopus
  16. G. L. Boye and O. Ampofo, “Medicinal plants in Ghana,” in Plants and Traditional Medicine, Wagner and N. R. Farnsworth, Eds., vol. 4, pp. 32-33, Academic Press, London, UK, 1990. View at Google Scholar
  17. C. W. Wright, J. D. Phillipson, S. O. Awe et al., “Antimalarial activity of cryptolepine and some other anhydronium bases,” Phytotherapy Research, vol. 10, no. 4, pp. 361–363, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. N. R. Mshana, D. K. Abbiw, E. Addae-Mensah et al., “Traditional medicine and pharmacopoeia: contribution to the revision of Ethnobotanical and Floristic Studies in Ghana,” Tech. Rep., Organization of African Unity/Scientific, Technical and Research committee, 2000. View at Google Scholar
  19. K. Kambu, Eléments de Phytothérapie Comparée: Plantes Médicinales Africaines, Centre de Recherches Pédagogiques, Kinshasa, Congo, 1990.
  20. L. Tona, K. Kambu, N. Ngimbi, K. Cimanga, and A. J. Vlietinck, “Antiamoebic and phytochemical screening of some Congolese medicinal plants,” Journal of Ethnopharmacology, vol. 61, no. 1, pp. 57–65, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Iwu, Handbook of African Medicinal Plants, CRC Press, Boca Raton, Fla, USA, 1993.
  22. D. E. Bierer, D. M. Fort, C. D. Mendez et al., “Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities,” Journal of Medicinal Chemistry, vol. 41, no. 6, pp. 894–901, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. D. E. Bierer, L. G. Dubenko, P. Zhang et al., “Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta,” Journal of Medicinal Chemistry, vol. 41, no. 15, pp. 2754–2764, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Luo, D. M. Fort, T. J. Carlson et al., “Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent,” Diabetic Medicine, vol. 15, no. 5, pp. 367–374, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. A. N. Tackie, M. H. M. Sharaf, P. L. Schiff, G. L. Boye, R. C. Crouch, and G. E. Martin, “Assignment of the proton and carbon NMR spectra of the indoloquinoline alkaloid cryptolepine,” Journal of Heterocyclic Chemistry, vol. 28, no. 5, pp. 1429–1435, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Claude, B. Lydia, W. Paul et al., “Efficacy of Cryptolepis sanguinolenta root extract on slow-growing rifampicin resistant Mycobacterium tuberculosis,” Journal of Medicinal Plants Research, vol. 6, no. 7, pp. 1140–1146, 2012. View at Publisher · View at Google Scholar
  27. A. Paulo, E. T. Gomes, J. Steele, D. C. Warhurst, and P. J. Houghton, “Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots,” Planta Medica, vol. 66, no. 1, pp. 30–34, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. H. J. T. Venter and R. L. Verhoeven, “A tribal classification of the Periplocoideae (Apocynaceae),” International Association for Plant Taxonomy, vol. 46, no. 4, pp. 705–720, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Brink and E. G. Achigan-Dako, “Fibres,” in Plant Resources of Tropical Africa (Prota), p. 109, Earthprint Limited, Stevenage, UK, 2012. View at Google Scholar
  30. C. Ansah, H. R. Otsyina, M. Duwiejua et al., “Toxicological assessment of Cryptolepis sanguinolenta for possible use in veterinary medicine,” Journal of Veterinary Medicine and Animal Health, vol. 1, no. 1, pp. 11–16, 2009. View at Google Scholar
  31. Y. Ameyaw, “Morpho-histological characters for the identification of Cryptolepis sanguinolenta (Lindl.) Schtr,” International Journal of Science and Nature, vol. 3, no. 2, pp. 331–339, 2012. View at Google Scholar
  32. C. Thornell, “Wild plant names in the Mpiemo language,” Africa and Asia, vol. 4, pp. 57-58, 2004. View at Google Scholar
  33. V. Y. A. Barku, Y. Opoku-Boahen, and E. Y. Dzotsi, “Isolation and pharmacological activities of alkaloids from Cryptolepis sanguinolenta (Lindl) schlt,” International Research Journal of Biochemistry and Bioinformatics, vol. 2, no. 3, pp. 58–61, 2012. View at Google Scholar
  34. C. B. Yakubu, NIBIMA, A Wonder Plant for Malaria Treatment, African Media and Malaria Research Network, 3rd edition, 2006, http://www.eyesonmalaria.org/content/editorial.
  35. A. A. Agboke, A. A. Attama, and M. A. Momoh, “Evaluation of the antimicrobial activities of crude extract of Cryptolepis sanguinolenta and Crateva adansonii leaves and their interactions,” Journal of Applied Pharmaceutical Science, vol. 1, no. 10, pp. 85–89, 2011. View at Google Scholar · View at Scopus
  36. M. Addy, “Cryptolepis: an African traditional medicine that provides hope for malaria victims,” HerbalGram, vol. 60, pp. 54–59, 2003. View at Google Scholar
  37. J. Hutchinson and J. M. Dalziel, Flora of Tropical West Africa, The Whitefrairs Press Ltd., London, UK, 1963.
  38. A. Paulo and P. J. Houghton, “Chemotaxonomic analysis of the genus Cryptolepis,” Biochemical Systematics and Ecology, vol. 31, no. 2, pp. 155–166, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. G. L. Boye, Ghana Herbal Pharmacopoeia, The Advert Press, Osu, Ghana, 1st edition, 1992.
  40. A. Sofowora, Medicinal Plants and Traditional Medicine in Africa, vol. 1, The Pitman Press Limited, Bath, UK, 2nd edition, 1984.
  41. Y. Ameyaw and G. Duker-Eshun, “The alkaloid contents of the ethno-plant organs of three antimalarial medicinal plant species in the eastern region of Ghana,” International Journal of Chemical Sciences, vol. 7, no. 1, pp. 48–58, 2009. View at Google Scholar
  42. F. C. Mills-Robertson, S. C. K. Tay, G. Duker-Eshun, W. Walana, and K. Badu, “In vitro antimicrobial activity of ethanolic fractions of Cryptolepis sanguinolenta,” Annals of Clinical Microbiology and Antimicrobials, vol. 11, article 16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. F. C. Mills-Robertson, F. A. Aboagye, G. Duker-Eshun, S. Kaminta, and S. Agbeve, “In vitro antimicrobial activity of Cryptolepis sanguinolenta (periplocaceae),” African Journal of Pharmacy and Pharmacology, vol. 3, no. 10, pp. 476–480, 2009. View at Google Scholar · View at Scopus
  44. E. Delvaux, “Sur la Cryptolepine. (On Cryptolepine.),” Journal de pharmacie de Belgique, vol. 13, article 955, 1931. View at Google Scholar
  45. S. Y. Ablordeppey, P. Fan, S. Li, A. M. Clark, and C. D. Hufford, “Substituted indoloquinolines as new antifungal agents,” Bioorganic & Medicinal Chemistry, vol. 10, no. 5, pp. 1337–1346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. B. K. Noamesi and S. O. A. Bamgbose, “The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens,” Planta Medica, vol. 39, no. 1, pp. 51–56, 1980. View at Publisher · View at Google Scholar · View at Scopus
  47. A. N. Tackie, G. L. Boye, M. H. M. Sharaf et al., “Cryptospirolepine, a unique spiro-nonacyclic alkaloid isolated from Cryptolepis sanguinolenta,” Journal of Natural Products, vol. 56, no. 5, pp. 653–670, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-L. Pousset, M.-T. Martin, A. Jossang, and B. Bodo, “Isocryptolepine from Cryptolepis sanguinolenta,” Phytochemistry, vol. 39, no. 3, pp. 735-736, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. M. H. M. Sharaf, P. L. Schiff Jr., A. N. Tackie, C. H. Phoebe Jr., and G. E. Martin, “Two new indoloquinoline alkaloids from Cryptolepis sanguinolenta: cryptosanguinolentine and cryptotackieine,” Journal of Heterocyclic Chemistry, vol. 33, no. 2, pp. 239–243, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. M. H. M. Sharaf, P. L. Schiff Jr., A. N. Tackie et al., “The isolation and structure determination of cryptomisrine, a novel indolo[3,2-b]quinoline dimeric alkaloid from Cryptolepis sanguinolenta,” Journal of Heterocyclic Chemistry, vol. 33, no. 3, pp. 789–797, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. P. T. Parvatkar, P. S. Parameswaran, and S. G. Tilve, “Isolation, biological activities and synthesis of indoloquinoline alkaloids: Cryptolepine, isocryptolepine and neocryptolepine,” Current Organic Chemistry, vol. 15, no. 7, pp. 1036–1057, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Cimanga, T. De Bruyne, L. Pieters, A. J. Vlietinck, and C. A. Turger, “In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta,” Journal of Natural Products, vol. 60, no. 7, pp. 688–691, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Paulo, E. T. Gomes, and P. J. Houghton, “New alkaloids from Cryptolepis sanguinolenta,” Journal of Natural Products, vol. 58, no. 10, pp. 1485–1491, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. R. C. Crouch, A. O. Davis, T. D. Spitzer et al., “Elucidation of the structure of quindolinone, a minor alkaloid of cryptolepis sanguinolenta: submilligram 1H‐13C and 1H‐15N heteronuclear shift correlation experiments using micro inverse‐detection,” Journal of Heterocyclic Chemistry, vol. 32, no. 3, pp. 1077–1080, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Grellier, L. Ramiaramanana, V. Millerioux et al., “Antimalarial activity of cryptolepine and isocryptolepine, alkaloids isolated from Cryptolepis sanguinolenta,” Phytotherapy Research, vol. 10, no. 4, pp. 317–321, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. J. B. Harborne, Phytochemical Methods, Chapman and Hall, London, UK, 1974.
  57. M. O. M. Tanira, A. K. Bashir, R. Dib, C. S. Goodwin, I. A. Wasfi, and N. R. Banna, “Antimicrobial and phytochemical screening of medicinal plants of the United Arab Emirates,” Journal of Ethnopharmacology, vol. 41, no. 3, pp. 201–205, 1994. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Komlaga, C. Agyare, R. A. Dickson et al., “Medicinal plants and finished marketed herbal products used in the treatment of malaria in the Ashanti region, Ghana,” Journal of Ethnopharmacology, vol. 172, pp. 333–346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Frederich, M. Tits, and L. Angenot, “Potential antimalarial activity of indole alkaloids,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 102, no. 1, pp. 11–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. G. C. Kirby, A. Paine, D. C. Warhurst, B. K. Noamese, and J. D. Phillipson, “In vitro and in vivo antimalarial activity of cryptolepine, a plant‐derived indoloquinoline,” Phytotherapy Research, vol. 9, no. 5, pp. 359–363, 1995. View at Publisher · View at Google Scholar · View at Scopus
  61. O. Onyeibor, S. L. Croft, H. I. Dodson et al., “Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action,” Journal of Medicinal Chemistry, vol. 48, no. 7, pp. 2701–2709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. A. F. Donkor, Efficacy, pharmacokinetics and safety evaluation of cryptolepine-artemisinin based combinations in the management of uncomplicated malaria [Ph.D. thesis], Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, 2016.
  63. K. A. Bugyei, G. L. Boye, and M. E. Addy, “Clinical efficacy of a tea-bag formulation of Cryptolepis sanguinolenta root in the treatment of acute uncomplicated falciparum malaria,” Ghana Medical Journal, vol. 44, no. 1, pp. 3–9, 2010. View at Publisher · View at Google Scholar
  64. A. Paulo, A. Duarte, and E. T. Gomes, “In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids,” Journal of Ethnopharmacology, vol. 44, no. 2, pp. 127–130, 1994. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Cimanga, L. Pieters, M. Claeys, D. Vanden Berghe, and A. J. Vlietinck, “Biological activities of cryptolepine, an alkaloid from Cryptolepis sanguinolenta,” Planta Medica, vol. 57, no. 2, pp. A98–A99, 1991. View at Publisher · View at Google Scholar · View at Scopus
  66. I. K. Sawer, M. I. Berry, M. W. Brown, and J. L. Ford, “The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiae,” Journal of Applied Bacteriology, vol. 79, no. 3, pp. 314–321, 1995. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Ansah, A. Khan, and N. J. Gooderham, “In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine,” Toxicology, vol. 208, no. 1, pp. 141–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Ansah and N. J. Gooderham, “The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxic,” Toxicological Sciences, vol. 70, no. 2, pp. 245–251, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Bonjean, M. C. De Pauw-Gillet, M. P. Defresne et al., “The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells,” Biochemistry, vol. 37, no. 15, pp. 5136–5146, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. J. N. Lisgarten, M. Coll, J. Portugal, C. W. Wright, and J. Aymami, “The antimalarial and cytotoxic drug cryptolepine intercalates into dna at cytosine-cytosine sites,” Nature Structural & Molecular Biology, vol. 9, no. 1, pp. 57–60, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Guittat, P. Alberti, F. Rosu et al., “Interactions of cryptolepine and neocryptolepine with unsual DNA structures,” Biochimie, vol. 85, no. 5, pp. 535–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. O. Silva, A. Duarte, J. Cabrita, M. Pimentel, A. Diniz, and E. Gomes, “Antimicrobial activity of Guinea-Bissau traditional remedies,” Journal of Ethnopharmacology, vol. 50, no. 1, pp. 55–59, 1996. View at Publisher · View at Google Scholar · View at Scopus
  73. E. O. Ekundayo and L. I. Ezeogu, “Evaluation of antimicrobial activities of extracts of five plants used in traditional medicine in Nigeria,” International Journal of Tropical Medicine, vol. 1, no. 2, pp. 93–96, 2006. View at Google Scholar
  74. S. Y. Gbedema, F. Adu, M. T. Bayor et al., “Enhancement of antibacterial activity of amoxicillin by some Ghanaian medicinal plant extracts,” International Journal of Pharma Sciences and Research, vol. 1, no. 11, pp. 145–152, 2010. View at Google Scholar
  75. K. Cimanga, T. De Bruyne, L. Pieters et al., “Antibacterial and antifungal activities of neocryptolepine, biscryptolepine and cryptoquindoline, alkaloids isolated from Cryptolepis sanguinolenta,” Phytomedicine, vol. 5, no. 3, pp. 209–214, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. O. Olajide, A. Pinheiro de Oliveira, J. Unekwe, C. Wright, and B. Fiebich, “Cryptolepis sanguinolenta (Lindl.) Schltr. root extract inhibits prostaglandin production in IL-1b stimulated SK-N-SH neuronal cells,” Planta Medica, vol. 76, no. 12, 2010. View at Publisher · View at Google Scholar
  77. O. A. Olajide, H. S. Bhatia, A. C. P. De Oliveira, C. W. Wright, and B. L. Fiebich, “Anti-neuroinflammatory properties of synthetic cryptolepine in human neuroblastoma cells: possible involvement of NF-κB and p38 MAPK inhibition,” European Journal of Medicinal Chemistry, vol. 63, pp. 333–339, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Ansah and K. B. Mensah, “A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine,” Ghana Medical Journal, vol. 47, no. 3, pp. 137–147, 2013. View at Google Scholar · View at Scopus
  79. U. E. Odoh, C. O. Ezugwu, and J. U. Adimegwu, “Phytochemical and anti-inflammatory activity of methanol root extract of Cryptolepis sanguinolenta (Periplocaceae),” Journal of Pharmaceutical and Allied Sciences, vol. 9, no. 3, pp. 1580–1586, 2012. View at Google Scholar
  80. M. A. Efunshile, B. A. F. Ngwu, J. A. L. Kurtzhals, S. Sahar, B. König, and C. R. Stensvold, “Molecular detection of the carriage rate of four intestinal protozoa with real-time polymerase chain reaction: possible overdiagnosis of entamoeba histolytica in Nigeria,” The American Journal of Tropical Medicine and Hygiene, vol. 93, no. 2, pp. 257–262, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Wang, M. Świtalska, M.-Y. Wu et al., “Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines,” European Journal of Medicinal Chemistry, vol. 78, pp. 314–323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. V. R. Gudivaka, Synthesis, analysis and biological evaluation of novel indoloquinoline cryptolepine analogues as potential antitumour agents [Ph.D. thesis], Kingston University, London, Uk, 2014.
  83. O. A. Olajide, E. H. Heiss, D. Schachner et al., “Synthetic cryptolepine inhibits DNA binding of NF-kappaB,” Bioorganic & Medicinal Chemistry Letters, vol. 15, pp. 43–49, 2007. View at Google Scholar
  84. H. Zhu and N. J. Gooderham, “Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells,” Toxicological Sciences, vol. 91, no. 1, pp. 132–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. O. A. Olajide, A. Olumayokun, and C. W. Wright, “Cryptolepine induced apoptosis in TNFalpha stimulated A549 lung carcinoma cells through NF-kappaB signalling pathway,” Proceedings of the British Pharmacological Society, vol. 11, no. 3, article 224, 2014. View at Google Scholar
  86. H. C. Pal and S. K. Katiyar, “Cryptolepine, a plant alkaloid, inhibits the growth of non-melanoma skin cancer cells through inhibition of topoisomerase and induction of DNA damage,” Molecules, vol. 21, no. 12, article 1758, 2016. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Ansah, E. A. Mfoafo, E. Woode, C. Opoku-Okrah, W. K. B. A. Owiredu, and M. Duwiejua, “Toxicological evaluation of the anti-malarial herb Cryptolepis sanguinolenta in rodents,” Journal of Pharmacology and Toxicology, vol. 3, no. 5, pp. 335–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Cimanga, Y. Li, T. De Bruyne et al., “Inhibitors of xanthine oxidase and scavengers of superoxide anions from Cryptolepis sanguinolenta (Lindl.) Schlechter (Periplocaceae),” Pharmacy and Pharmacology Communications, vol. 6, no. 7, pp. 321–325, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Akhigbe, O. Adewumi, L. Okeleji, K. Mujaidu, S. Olaleye, and A. Ajayi, “Effect of ethanolic extract of Cryptolepis sanguinolenta stem on in vivo and in vitro glucose absorption and transport: mechanism of its antidiabetic activity,” Indian Journal of Endocrinology and Metabolism, vol. 16, no. 7, p. 91, 2012. View at Publisher · View at Google Scholar
  90. E. O. Ameyaw, G. A. Koffuor, K. K. Asare et al., “Cryptolepine, an indoloquinoline alkaloid, in the management of diabetes mellitus and its associated complications,” Journal of Intercultural Ethnopharmacology, vol. 5, no. 3, pp. 263–273, 2016. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Ansah, K. B. Mensah, E. Woode, and M. Duwiejua, “Reproductive and developmental toxicity of Cryptolepis sanguinolenta in mice,” Research Journal of Pharmacology, vol. 4, no. 1, pp. 9–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. H. W. Rauwald, M. Kober, E. Mutschler, and G. Lambrecht, “Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors,” Planta Medica, vol. 58, no. 6, pp. 486–488, 1992. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Ajayi, R. Akhigbe, T. Iyiola, O. Adewumi, and S. Olaleye, “Gastric secretagogue action of Cryptolepis sanguinolenta in the perfused stomach of anesthetized rats,” International Journal of Medicine and Biomedical Research, vol. 1, no. 1, pp. 62–67, 2012. View at Publisher · View at Google Scholar
  94. K. B. Mensah, Reproductive and developmental toxicity of the aqueous root extract of the antimalarial herbal Cryptolepis sanguinolenta (Lindl.) Schltr (Periplocaceae) in experimental animals [Ph.D. thesis], Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, 2011.